CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CCRN on Nasdaq
CUSIP
227483104
Type / Class
Equity / Common Stock
Shares outstanding
32.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.7M
Holdings value
$450M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
162
Number of buys
77
Number of sells
-93
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% -13.3% $34.4M -$5.59M 2.47M -14% BlackRock, Inc. Jun 30, 2025
Magnetar Financial LLC 7.2% +19.5% $32.7M $5.32M 2.32M +19.4% Magnetar Financial LLC Dec 31, 2024
ALLIANCEBERNSTEIN L.P. 5.9% -17.1% $27.4M -$5.86M 1.93M -17.6% AllianceBernstein L.P. Sep 30, 2025
VANGUARD GROUP INC 5.67% $25.8M 1.83M The Vanguard Group Dec 31, 2024
GOLDMAN SACHS GROUP INC 3.9% -31.7% $18.1M -$8.75M 1.27M -32.6% THE GOLDMAN SACHS GROUP, INC. Sep 30, 2025

Institutional Holders of CROSS COUNTRY HEALTHCARE INC - Common Stock (CCRN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.7M $450M +$2.87M $14.20 162
2025 Q2 31.5M $411M -$9.05M $13.05 159
2025 Q1 32M $476M -$6.9M $14.89 158
2024 Q4 31.7M $576M -$25.6M $18.16 173
2024 Q3 34.3M $461M +$2.42M $13.44 177
2024 Q2 34.5M $477M -$18.3M $13.84 161
2024 Q1 35.5M $664M -$22.7M $18.72 171
2023 Q4 87.1K $1.97M +$951K $22.64 2
2023 Q3 37.1M $919M -$5.46M $24.79 184
2023 Q2 36.6M $1.03B -$7.5M $28.08 187
2023 Q1 37.5M $836M +$27.3M $22.32 196
2022 Q4 35.9M $954M -$17.7M $26.57 229
2022 Q3 35.7M $1.01B +$26.2M $28.37 184
2022 Q2 35.8M $744M +$16.4M $20.83 170
2022 Q1 35M $759M +$25.5M $21.67 187
2021 Q4 34M $943M -$16.6M $27.76 178
2021 Q3 34.3M $729M +$2.72M $21.24 156
2021 Q2 34.1M $564M +$2.62M $16.51 145
2021 Q1 33.6M $419M +$8.24M $12.49 127
2020 Q4 30.5M $271M -$2.72M $8.87 117
2020 Q3 33.4M $217M +$594K $6.49 112
2020 Q2 31.6M $194M -$11.5M $6.16 118
2020 Q1 35.4M $239M -$1.89M $6.74 133
2019 Q4 35.3M $410M +$5.66M $11.62 134
2019 Q3 34.2M $352M +$4.03M $10.30 125
2019 Q2 34.2M $320M +$3.2M $9.38 117
2019 Q1 34.8M $244M +$16.8M $7.03 125
2018 Q4 31.7M $233M -$5.42M $7.33 137
2018 Q3 32.9M $288M +$2.6M $8.73 130
2018 Q2 32.7M $368M -$24.1M $11.25 135
2018 Q1 34.4M $383M -$1.57M $11.11 131
2017 Q4 34.4M $440M +$9.36M $12.76 141
2017 Q3 33.6M $477M -$13.9M $14.23 147
2017 Q2 34.1M $441M +$9.64M $12.91 138
2017 Q1 34M $488M +$60.6M $14.36 150
2016 Q4 32.2M $503M +$4.35M $15.61 152
2016 Q3 32.4M $382M +$6.18M $11.78 143
2016 Q2 29.5M $410M +$408K $13.92 143
2016 Q1 32.2M $374M -$5M $11.63 149
2015 Q4 31.4M $514M +$39M $16.39 163
2015 Q3 30.5M $415M +$7.12M $13.61 141
2015 Q2 29.4M $373M -$6.82M $12.68 120
2015 Q1 30.6M $363M +$10.5M $11.86 118
2014 Q4 29.8M $371M -$133K $12.48 123
2014 Q3 30M $279M +$9.55M $9.29 121
2014 Q2 25.6M $167M -$11.1M $6.52 114
2014 Q1 26.8M $216M -$9.1M $8.07 117